Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A)

被引:6
作者
Libroia, A
Verga, U
Vecchi, G
Banfi, F
Zurleni, F
Quadro, L
Scurini, C
Fattoruso, O
Colantuoni, V
机构
[1] Osped Maggiore Niguarda, Div Endocrinol, Milano, Italy
[2] Osped Maggiore Niguarda, Div Radiol, Milano, Italy
[3] Osped Maggiore Niguarda, Nucl Med Serv, Milano, Italy
[4] Osped Maggiore Niguarda, Div Chirurg Pizzamiglio 2, Milano, Italy
[5] Univ Naples, Dipartimento Biochim & Biotecnol Med, I-80138 Naples, Italy
关键词
multiple endocrine neoplasia type 2A; MEN; 2A; genetic analysts; RET proto-oncogene; chorionic villi DNA;
D O I
10.1007/BF03350320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reports the results of a 17-year-long follow-up covering 17 members of a family affected by multiple endocrine neoplasia (MEN) type 2 A, first diagnosed in 1980. This family is enrolled in our screening program. The thyroid, parathyroid and adrenal glands of the family members were investigated using the most sophisticated and sensitive techniques which have become available during this period, and their DNA was genetically tested for detecting RET mutations. Thanks to the combination of these two approaches it was possible to confirm the diagnosis in the members concerned from the genetic point of view, and to achieve an early diagnosis in the young members of the last generation before the clinical onset of the disease. The detection of a RET mutation also prompted a prophylactic thyroidectomy in a four year-old boy, in a pre-tumoral stage of the disease. Lastly, evidence is provided that genetic analysis of the DNA of the chorionic villi can be carried out as a prenatal test during routine amniocentesis. (C) 1998, Editrice Kurtis.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 20 条
[1]  
BOLINO A, 1995, ONCOGENE, V10, P2415
[2]   Investigation of phaeochromocytoma [J].
Bouloux, PMG ;
Fakeeh, M .
CLINICAL ENDOCRINOLOGY, 1995, 43 (06) :657-664
[3]   PHEOCHROMOCYTOMA IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A - SURVEY OF 100 CASES [J].
CASANOVA, S ;
ROSENBERGBOURGIN, M ;
FARKAS, D ;
CALMETTES, C ;
FEINGOLD, N ;
HESHMATI, HM ;
COHEN, R ;
CONTEDEVOLX, B ;
GUILLAUSSEAU, PJ ;
HOUDENT, C ;
BIGORGNE, JC ;
BOITEAU, V ;
CARON, J ;
MODIGLIANI, E .
CLINICAL ENDOCRINOLOGY, 1993, 38 (05) :531-537
[4]  
DELELLIS RA, 1995, LAB INVEST, V72, P494
[5]   MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].
DONISKELLER, H ;
DOU, SS ;
CHI, D ;
CARLSON, KM ;
TOSHIMA, K ;
LAIRMORE, TC ;
HOWE, JR ;
MOLEY, JF ;
GOODFELLOW, P ;
WELLS, SA .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856
[6]   The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].
Eng, C ;
Clayton, D ;
Schuffenecker, I ;
Lenoir, G ;
Cote, G ;
Gagel, RF ;
vanAmstel, HKP ;
Lips, CJM ;
Nishisho, I ;
Takai, SI ;
Marsh, DJ ;
Robinson, BG ;
FrankRaue, K ;
Raue, F ;
Xue, FY ;
Noll, WW ;
Romei, C ;
Pacini, F ;
Fink, M ;
Niederle, B ;
Zedenius, J ;
Nordenskjold, M ;
Komminoth, P ;
Hendy, GN ;
Gharib, H ;
Thibodeau, SN ;
Lacroix, A ;
Frilling, A ;
Ponder, BAJ ;
Mulligan, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579
[7]  
FATTORUSO O, IN PRESS HUMAN MUTAT
[8]  
HINDIE F, 1995, J CLIN ENDOCR METAB, V80, P1
[9]  
KAPLAN MM, 1992, H FORD HOSP MED J, V40, P3
[10]   INVIVO SOMATOSTATIN RECEPTOR IMAGING IN MEDULLARY-THYROID CARCINOMA [J].
KWEKKEBOOM, DJ ;
REUBI, JC ;
LAMBERTS, SWJ ;
BRUINING, HA ;
MULDER, AH ;
OEI, HY ;
KRENNING, EP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1413-1417